Search results
Results From The WOW.Com Content Network
“GERD can irritate the vocal cords, which can cause hoarseness, especially earlier in the day,” Dr. Alexa Mieses Malchuk, a family physician based in Cary, N.C., tells Yahoo Life. “A person ...
Voice disorders can be divided into two broad categories: organic and functional. [9] The distinction between these broad classes stems from their cause, whereby organic dysphonia results from some sort of physiological change in one of the subsystems of speech (for voice, usually respiration, laryngeal anatomy, and/or other parts of the vocal tract are affected).
In October 2014, the U.S. Food and Drug Administration (FDA) issued a black box warning that losartan can cause fetal toxicity and should be discontinued as soon as pregnancy is detected. [19] [3] Using losartan while pregnant could result in fetal injury or death. [19] [3]
Rarer seizure types can cause involuntary ... losartan , statins ... There was moderate certainty of evidence that voice alteration or hoarseness risk may be 2.17(1. ...
Due to its low frequency of occurrence, more common causes of hoarseness should be considered when suspecting left recurrent laryngeal nerve palsy (LRLN).. When considering cardiovocal syndrome, the most common historical cause is a dilated left atrium due to mitral stenosis, but other causes, including pulmonary hypertension, [2] thoracic aortic aneurysms, an enlarged pulmonary artery [3] and ...
A medical and voice history can help distinguish patterns of misuse and phonotrauma to assist in diagnosis. [3] The primary perceptual sign of vocal fold cysts is hoarseness of the voice. [3] Diagnosis through perceptual means alone is difficult, therefore in the fourth component of diagnosis the patient often undergoes an imaging procedure.
The chance of drug-induced angioedema is extremely uncommon, however, as studies show incidence of less than 1%. [4] The reason this adverse effect may occur is due to the build-up of bradykinin, a vasodilator.
Losartan, the first ARB. Angiotensin II receptor blockers (ARBs), formally angiotensin II receptor type 1 (AT 1) antagonists, [1] also known as angiotensin receptor blockers, [2] [3] angiotensin II receptor antagonists, or AT 1 receptor antagonists, are a group of pharmaceuticals that bind to and inhibit the angiotensin II receptor type 1 (AT 1) and thereby block the arteriolar contraction and ...